FCMI
OREX
Foresite Capital Management III’s Orexigen Therapeutics, Inc. OREX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-380,530
| Closed | -$1.1M | – | 29 |
|
|
2017
Q2 | $1.1M | Hold |
380,530
| – | – | 0.36% | 20 |
|
|
2017
Q1 | $1.31M | Buy |
380,530
+126,273
| +50% | +$434K | 0.5% | 22 |
|
|
2016
Q4 | $442K | Hold |
254,257
| – | – | 0.19% | 20 |
|
|
2016
Q3 | $844K | Sell |
254,257
-2,288,318
| -90% | -$7.6M | 0.39% | 15 |
|
|
2016
Q2 | $1.09M | Sell |
2,542,575
-484,779
| -16% | -$208K | 0.75% | 15 |
|
|
2016
Q1 | $1.7M | Buy |
3,027,354
+27,354
| +0.9% | +$15.4K | 1.32% | 18 |
|
|
2015
Q4 | $5.16M | Buy |
+3,000,000
| New | +$5.16M | 4.58% | 9 |
|